Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JP-1730 in Advanced Parkinson's Disease
NCT00040209Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fipamezole in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Jun 2002; status: completed.
02
Drugs
fipamezole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00040209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040209.